Published online
doi:10.1084/jem.20081712
The Journal of Experimental Medicine, Vol. 206, No. 3, 525-534
The Rockefeller University Press, 0022-1007 $30.00
© Kleinschek et al.
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Melanie A. Kleinschek1,
Katia Boniface1,
Svetlana Sadekova2,
Jeff Grein2,
Erin E. Murphy2,
Scott P. Turner2,
Lisa Raskin2,
Bela Desai2,
William A. Faubion3,
Rene de Waal Malefyt1,
Robert H. Pierce2,
Terrill McClanahan2, and
Robert A. Kastelein1
1 Department of Immunology and 2 Department of Experimental Pathology and Pharmacology, Schering-Plough Biopharma, Palo Alto, CA 94304
3 Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905
CORRESPONDENCE Melanie A. Kleinschek: melanie.kleinschek{at}spcorp.com
The C-type lectin-like receptor CD161, which has recently been described to promote T cell expansion, is expressed on a discrete subset of human CD4 T cells. The function of such cells, however, has remained elusive. We now demonstrate that CD161+ CD4 T cells comprise a circulating and gut-resident T helper 17 (Th17) cell population. During Crohn's disease (CD), these CD161+ cells display an activated Th17 phenotype, as indicated by increased expression of interleukin (IL)-17, IL-22, and IL-23 receptor. CD161+ CD4 T cells from CD patients readily produce IL-17 and interferon
upon stimulation with IL-23, whereas, in healthy subjects, priming by additional inflammatory stimuli such as IL-1β was required to enable IL-23–induced cytokine release. Circulating CD161+ Th17 cells are imprinted for gut homing, as indicated by high levels of CC chemokine receptor 6 and integrin β7 expression. Supporting their colitogenic phenotype, CD161+ Th17 cells were found in increased numbers in the inflammatory infiltrate of CD lesions and induced expression of inflammatory mediators by intestinal cells. Our data identify CD161+ CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate destructive tissue inflammation.
© 2009 Kleinschek et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related Article
-
Flagging Th17 in Crohn's
- Amy Maxmen
J. Exp. Med. 2009 206: 492-493.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Shan, M., Cheng, H.-F., Song, L.-z., Roberts, L., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., Coxson, H. O., Storness-Bliss, C., Ramchandani, M., Lee, S.-H., Corry, D. B., Kheradmand, F.
(2009). Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema. Sci Transl Med
1: 4ra10-4ra10
[Abstract]
[Full Text]
-
Volpe, E., Touzot, M., Servant, N., Marloie-Provost, M.-A., Hupe, P., Barillot, E., Soumelis, V.
(2009). Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood
114: 3610-3614
[Abstract]
[Full Text]
-
Annunziato, F., Romagnani, S.
(2009). Do studies in humans better depict Th17 cells?. Blood
114: 2213-2219
[Abstract]
[Full Text]
-
Johnston, S. L, Edwards, M. R
(2009). Mechanisms of adverse effects of {beta}-agonists in asthma. Thorax
64: 739-741
[Full Text]
-
Doisne, J.-M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J.-B., Eberl, G., Benlagha, K.
(2009). Skin and Peripheral Lymph Node Invariant NKT Cells Are Mainly Retinoic Acid Receptor-Related Orphan Receptor {gamma}t+ and Respond Preferentially under Inflammatory Conditions. J. Immunol.
183: 2142-2149
[Abstract]
[Full Text]
-
Troy, A. E., Zaph, C., Du, Y., Taylor, B. C., Guild, K. J., Hunter, C. A., Saris, C. J. M., Artis, D.
(2009). IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis. J. Immunol.
183: 2037-2044
[Abstract]
[Full Text]